Found 7 matching trials
Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies N/A This study is not designed to test a hypothesis; rather, this study will pr...
Show More Location
Multiple Locations
Learn More & Join Trial
Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies PHASE1 This study will evaluate the safety, tolerability, and efficacy of Orca-T, ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT PHASE1 The study goal is to characterize the safety of the combination of Orca-T w...
Show More Location
Stanford University
Learn More & Join Trial
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies PHASE3 This study will evaluate the safety, tolerability, and efficacy of Orca-T, ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome PHASE2 This study will evaluate the safety, tolerability, and efficacy of Orca-T i...
Show More Location
UCLA Department of Medicine
Learn More & Join Trial
Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL PHASE1 To assess the safety of administering allogenic, donor-derived CD19/CD22-CA...
Show More Status
Active Not Recruiting
Location
Stanford Cancer Center
Learn More & Join Trial
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome PHASE1 This phase I trial tests the side effects and best dose of total marrow lym...
Show More Location
City of Hope Medical Center
Learn More & Join Trial